-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$33.00124.34% Upside
Recent Analyst Forecasts and Stock Ratings
Arcus Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. has been rated by research analysts at Citigroup, H.C. Wainwright, Morgan Stanley, Wells Fargo, Bank of America Securities, Barclays in the past 90 days.